Search results for " antagonism"

showing 10 items of 20 documents

Antagonism of the endophytic Bacillus subtilis strain AG1 to fungal pathogens that cause tracheomycotic deterioration of wine wood

2008

Grapevine trunk diseases can determine considerable losses in the worldwide wine industry. Symptoms of wood diseases are dead spurs, arms, cordons and same times vine death, due to cankers in the vascular tissue (Pascoe, 2000). Recent research has also showed a recrudescence either of escadisease or decay by Verticilliumdahliae and the occurrence of new wood alterations (Botryosphaeriarhodina; Mugnai et al., 1999; Wood et al., 2005; Bonfiglioliet al., 2007). Last investigations, carried out in Sicilian vineyards on fungi associated with xilematic“esca”symptoms, revealed the occurrence of genus Bacillusin wood tissues. A spore-producer Gram-positive bacterial isolate, named AG1, was identifi…

BACILLUS SUBTILIS ESCA FUNGI ANTAGONISM
researchProduct

Selectivity of pharmacological tools: implications for use in cell physiology. A Review in the Theme: Cell Signaling: Proteins, Pathways and Mechanis…

2014

Pharmacological inhibitors are frequently used to identify the receptors, receptor subtypes, and associated signaling pathways involved in physiological cell responses. Based on the effects of such inhibitors conclusions are drawn about the involvement of their assumed target or lack thereof. While such inhibitors can be useful tools for a better physiological understanding, their uncritical use can lead to incorrect conclusions. This article reviews the concept of inhibitor selectivity and its implication for cell physiology. Specifically, we discuss the implications of using inhibitor vs. activator approaches, issues of direct vs. indirect pathway modulation, implications of inverse agoni…

Cell physiologyCell signalingPhysiologyAdrenergic beta-AntagonistsCellAllosteric regulationImidazolesCell CommunicationCell BiologyAdrenergic beta-AgonistsBiologyPharmacologyIndirect pathway of movementCell Physiological PhenomenaReceptors G-Protein-CoupledFunctional antagonismmedicine.anatomical_structuremedicineAnimalsHumansSignal transductionReceptorNeuroscienceProtein BindingSignal TransductionAmerican Journal of Physiology-Cell Physiology
researchProduct

Evaluation and synthesis of 7-arylhydroxymethyltriazolopyridines as potential cardiovascular agents

2002

7-Arylhydroxymethyltriazolopyridines 3a-c and 4a-d were synthesized by regioselective lithiation of [1,2,3]triazolo[1,5-a]pyridines 1 and 2 and subsequent trapping of the 7-lithioderivatives formed using aryl aldehydes as electrophiles. The structural relationship between compounds 3a-c and 4a-d and arylethanolamines suggested their consideration as potential cardiovascular agents. A preliminary evaluation as vascular smooth muscle relaxants was carried out. These compounds did not act as α1-adrenoceptor antagonists and were unable to block calcium entry through voltage-dependent calcium channels. Abarca Gonzalez, Belen, Belen.Abarca@uv.es ; Ballesteros Campos, Rafael, Rafael.Ballesteros@uv…

ChemistryTriazolopyridines ; Lithiation reaction ; α1-adrenoceptor antagonism ; Calcium channels blockadeUNESCO::QUÍMICACalcium channels blockade:QUÍMICA::Química orgánica [UNESCO]Organic Chemistry:QUÍMICA [UNESCO]lcsh:QD241-441lcsh:Organic chemistryCardiovascular agentTriazolopyridinesα1-adrenoceptor antagonismUNESCO::QUÍMICA::Química orgánicaLithiation reactionHumanities
researchProduct

Medication-related osteonecrosis of the jaw associated with implant and regenerative treatments : systematic review

2019

Background The aim of this study was to determine if the treatment with bisphosphonates other anti-resorptive and antiangiogenic agents influences the success of regenerative and / or implant treatments. Material and Methods We reviewed the literature from the last 5 years in the PubMed database, using the following words: “Sinus Floor Augmentation”[Mesh] OR “Dental Implants”[Mesh]) OR “Guided Tissue Regeneration”[Mesh]) AND “Osteonecrosis”[Mesh]. The articles were selected following the inclusion and exclusion criteria and were evaluated using the 22 items of the STROBE declaration. The following PICO clinical question was applied: Does the treatment with agents associated with drug osteon…

Dental Restoration FailureSinus Floor AugmentationBone RegenerationDatabases FactualMEDLINESinus Floor AugmentationDentistryReviewRessenyes sistemàtiques (Investigació mèdica)law.invention03 medical and health sciences0302 clinical medicineRandomized controlled triallawSystematic reviews (Medical research)medicineOssosAnimalsHumansDental Restoration FailureMethodological qualityGeneral DentistryDental ImplantsBonesDiphosphonatesImplants dentalsbusiness.industryDental Implantation EndosseousDental implantsOsteonecrosisAntibodies Monoclonal030206 dentistryMedically compromised patients in Dentistrymedicine.disease:CIENCIAS MÉDICAS [UNESCO]OtorhinolaryngologyEfectes secundaris dels medicamentsInclusion and exclusion criteriaUNESCO::CIENCIAS MÉDICASDrug side effectsSurgeryImplantbusinessOsteonecrosis of the jawDrug Antagonism
researchProduct

Un endofita fungino in Eruca sativa Mill., probabile antagonista di Albugo candida (Pers. ex Hook) Kuntze.

2000

Eruca sativa Albugo candida endofita antagonismoSettore AGR/12 - Patologia Vegetale
researchProduct

Genomic conflicts and sexual antagonism in human health: Insights from oxytocin and testosterone

2015

We review the hypothesized and observed effects of two of the major forms of genomic conflicts, genomic imprinting and sexual antagonism, on human health. We focus on phenotypes mediated by peptide and steroid hormones (especially oxytocin and testosterone) because such hormones centrally mediate patterns of physical and behavioral resource allocation that underlie both forms of conflict. In early development, a suite of imprinted genes modulates the human oxytocinergic system as predicted from theory, with paternally inherited gene expression associated with higher oxytocin production, and increased solicitation to mothers by infants. This system is predicted to impact health through the i…

Geneticskinship theoryReviews and SynthesisBiologygenomic imprintingSexual dimorphismSexual conflictparental antagonismsexual conflictsexual antagonismGeneticsta1181EpigeneticsAlleleParent–offspring conflictGeneral Agricultural and Biological SciencesEvolutionary dynamicsGenomic imprintingEcology Evolution Behavior and Systematicsparent–offspring conflictMaladaptationEvolutionary Applications
researchProduct

Pharmacokinetic Interaction between Nevirapine and Nortriptyline in Rats: Inhibition of Nevirapine Metabolism by Nortriptyline

2014

ABSTRACTOne of the most frequent comorbidities of HIV infection is depression, with a lifetime prevalence of 22 to 45%. Therefore, it was decided to study a potential pharmacokinetic interaction between the nonnucleoside reverse transcriptase inhibitor nevirapine (NVP) and the tricyclic antidepressant nortriptyline (NT). NVP and NT were administered to rats either orally, intraduodenally, or intravenously, and the changes in plasma levels and pharmacokinetic parameters were analyzed. Experiments with rat and human hepatic microsomes were carried out to evaluate the inhibitory effects of NT on NVP metabolism. NVP plasma concentrations were significantly higher when this drug was coadminister…

MaleNevirapineAnti-HIV AgentsAdministration OralNortriptylineAntidepressive Agents TricyclicPharmacologyPharmacokineticsimmune system diseasesIn vivomedicineAnimalsHumansPharmacology (medical)NevirapineRats WistarBiotransformationPharmacologyDose-Response Relationship DrugReverse-transcriptase inhibitorbusiness.industryvirus diseasesRatsDose–response relationshipInfectious DiseasesArea Under CurveInjections IntravenousMicrosomes LiverMicrosomeReverse Transcriptase InhibitorsNortriptylinebusinessDrug AntagonismDrug metabolismmedicine.drugAntimicrobial Agents and Chemotherapy
researchProduct

Ascorbic acid antagonizes ethanol-induced locomotor activity in the open-field.

1999

Abstract It has been reported that ascorbic acid (AA) antagonizes the physiological and behavioral effects of dopamine (DA). AA reduces locomotor activity induced by dopaminergic agonist drugs. Also, AA amplifies the action of antidopaminergic drugs. Ethanol, like other drugs, produces a release of DA in the mesolimbic pathway, and at some doses, induces locomotor activity in mice. The ethanol-induced locomotor activity could be dopamine-dependent because it can be reduced by antidopaminergic drugs. In the present study, we investigated whether an acute administration of AA reduces ethanol-induced locomotor behavior. AA, at doses (0.0, 21.85, 87.5, 175, 350, and 1400 mg/kg) was injected IP …

MaleTime FactorsClinical BiochemistryMesolimbic pathwayAscorbic AcidPharmacologyMotor ActivityToxicologyBiochemistryOpen fieldAntioxidantsBehavioral Neurosciencechemistry.chemical_compoundMiceDopaminemedicineAnimalsAmphetamineBiological PsychiatryPharmacologyAnalysis of VarianceEthanolDose-Response Relationship DrugEthanolIllicit DrugsDopaminergicAscorbic acidMechanism of actionchemistrymedicine.symptomDrug Antagonismmedicine.drugPharmacology, biochemistry, and behavior
researchProduct

Molecular markers and biological targeted therapies in metastatic colorectal cancer: expert opinion and recommendations derived from the 11th ESMO/Wo…

2010

The article summarizes the expert discussion and recommendations on the use of molecular markers and of biological targeted therapies in metastatic colorectal cancer (mCRC), as well as a proposed treatment decision strategy for mCRC treatment. The meeting was conducted during the 11th ESMO/World Gastrointestinal Cancer Congress (WGICC) in Barcelona in June 2009. The manuscript describes the outcome of an expert discussion leading to an expert recommendation. The increasing knowledge on clinical and molecular markers and the availability of biological targeted therapies have major implications in the optimal management in mCRC. 21 Suppl 6 vi1 10

OncologyColorectal cancermedicine.medical_treatmentBraf proteinGastroenterologyMetastasisDrug antagonismTargeted therapyMetastasisAntineoplastic agentsPathologyConference paperBiological markersPredictive markerHematologyPrognosisChemotherapy regimenAntineoplastic agentOncologyProto-oncogene proteinsRas proteinHumanReceptormedicine.medical_specialtyNeoplasm metastasisRas proteinsMEDLINEOncoproteinColorectal neoplasmsProto-oncogene proteins b-rafInternal medicineGeneticsmedicineHumansGastrointestinal cancerColorectal tumorB raf kinaseEpidermal growth factor receptorKras proteinbusiness.industryEpidermal growth factorCancermedicine.diseasedigestive system diseasesBiological markerMetabolismSpainMutationCarcinoembryonic antigenMicrosatellite instabilitybusinessAnnals of Oncology
researchProduct

In "semi-vivo" antagonism of Acremonium byssoides towards Plasmopara viticola.

2008

P. viticola A. byssoides antagonism
researchProduct